Ten years ago, the average survival rate for patients with glioblastoma multiforme (GBM) – the most aggressive form of brain cancer - was less than one year. Thanks to recent advances, it is now approximately eighteen months, with some patients living beyond the three- and five-year marks. The inaugural A BRILLIANT NIGHT will raise much-needed funds for the Next Generation of Brain Cancer Treatment and TARGiT, two ground-breaking brain tumor research programs at The Neuro.
With your help, The Neuro’s doctors will use precision medicine and new therapeutics that prevent brain cancer invasion to provide patients with more effective treatments and a reduced risk of relapse.
Please help The Neuro be at the helm of this progress and bring a brighter future to those afflicted with this terrible disease.
Location: Rio Tinto Alcan Planetarium